CPAP APAP denied as experimental or investigational by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for cpap apap are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Denied Your CPAP/APAP as "Experimental" — and How to Appeal

A denial categorizing CPAP or APAP as experimental or investigational for obstructive sleep apnea is factually incorrect for most standard indications. CPAP is one of the most extensively studied and guideline-supported treatments in sleep medicine, with decades of clinical use and broad professional society endorsement. When UHC issues this type of denial, it almost always reflects one of three problems: (1) the procedure or device code submitted is associated with a newer indication or feature (e.g., a specific adaptive servo-ventilation mode) that UHC does classify as investigational; (2) the diagnosis codes on the claim do not match an approved indication; or (3) the appeal is reaching you in error.

## Why This Denial Is Appealable

For standard OSA indications, the established clinical evidence base and professional society endorsement (including guidelines from the American Academy of Sleep Medicine) directly contradict an "experimental" classification. If the denial is based on a billing or coding mismatch rather than the device itself, the appeal can be resolved by correcting the code. If UHC's own medical policy cites a particular evidence standard, you can demonstrate the clinical record meets that standard.

## Federal Appeal Framework

• ERISA §503: Employer-plan members have the right to a full-and-fair review by a clinically qualified reviewer who was not party to the original denial. An experimental-therapy denial triggers the right to have a specialist in the relevant field review the case.
• ACA §2719 / External Review: For experimental/investigational denials specifically, federal law guarantees access to external review by an IRO with relevant expertise. File within approximately four months of your final internal denial — confirm the exact deadline on the denial notice.
• Expedited review: Available if clinical urgency is present.

## Concrete Appeal Steps and Timeline

1. Obtain the specific UHC medical policy number and version cited in the denial letter, then download the current version from UHC's website to verify which indications are classified as experimental. 2. Confirm the procedure and diagnosis codes on the claim and correct any coding error with your DME supplier before or alongside the appeal. 3. File the Level 1 internal appeal within the deadline on your denial letter (typically 180 days). 4. If denied internally, file for external IRO review within four months.

## Documentation to Gather

• Sleep study report: Polysomnogram or home sleep apnea test confirming OSA — the diagnosis underlying the device request.
• Device and indication match: The device prescribing information or FDA clearance letter showing the device is cleared for the documented indication.
• Prescriber medical-necessity letter: States the diagnosis, confirms that CPAP/APAP is standard-of-care for this indication per applicable clinical guidelines, and identifies the relevant professional society recommendation.
• Coding documentation: The DME supplier's confirmation of the HCPCS code(s) billed and their clinical description — to rebut any coding-mismatch basis for the denial.

## Criteria-Mapping Structure

Copy each criterion from UHC's medical policy that defines "experimental" versus "covered." For each criterion (e.g., "FDA clearance," "published peer-reviewed evidence," "professional society endorsement"), write a one-sentence response citing the exact supporting document in your packet. An IRO reviewer who is a sleep medicine specialist will readily recognize CPAP/APAP as standard therapy and will look for this mapping to confirm the denial was unsupported.